Split-luciferase complementation to measure soluble epoxide hydrolase dimerization

Case ID:
Web Published:

Technology Overview
Soluble epoxide hydrolase (sEH) inhibition is a therapeutic target for a large number of cardiovascular diseases. Disrupting dimerization of sEH reduces hydrolase activity and shifts the sub-cellular localization of sEH to peroxisomes. The current technology is a split-firefly luciferase assay that not only measures disruption of sEH dimerization as a means of inhibition, but also acts as a high throughput screen for small molecules that could inhibit sEH dimerization.

Nelson JW, et. Al, “Soluble epoxide hydrolase dimerization is required for hydrolase activity. J Biol Chem. 2013 Mar 15;288(11):7697-7703. Link

Licensing Opportunity
This technology is available for licensing.

Patent Information:
For Information, Contact:
Lisa Lukaesko
Technology Development Manager
Oregon Health & Science University
Jonathan Nelson
Nabil Alkayed
Xiangshu Xiao
Biological Materials
Research Tools - Screening
© 2023. All Rights Reserved. Powered by Inteum